Benzinga | Nov 29, 2021 09:23AM EST

Biofrontera Reaches Out-Of-Court Settlement With DUSA Pharmaceuticals, Inc.; Agrees To Pay DUSA $22.5M In Settlement Of Potential Claims

-Reuters